Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.

In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other firms that posted double-digit gains on Thursday. Wall Street’s main indices ...

Hims & Hers Health, Inc. (HIMS) shares rallied 27.7% in the last trading session to close at $59.18. This move can be attributable to notable volume with a higher number of shares being traded ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the ...

Hims & Hers has capitalized on the outsize consumer demand for obesity drugs. (Hims & Hers Health) Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

When you buy something using these coupons, we may earn a small affiliate commission. TIME is involved in the coupon selection process, working closely with Savings United to bring you the best ...